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THE ABSORPTION AND METABOLISM OF N-ACETYL-D-GLHCOSAMINE 
AND D-GLUCOSAMINE IN THE INTACT RAT
CHAPTER I 
INTRODUCTION
Corl (1), in the introduction to his classic paper, "The Fate of 
Sugar in the Animal Body” , summarizes very concisely the problems 
involved in obtaining information on the overall metabolism of a sugar 
in the intact animal. He states; "Without an accurate knowledge of 
the laws of intestinal absorption it would seem impossible to follow 
the fate of sugar in the animal organism on a quantitative basis. For 
convenience, the fate of sugar in the animal body may be divided into 
four steps; first, the absorption from the intestinal tract; second, 
the passage through the blood and occasionally elimination in the 
urine; third, the penetration into the tissues; and fourth, the 
disposal in the tissues".
In the studies reported here, the investigation involves the 
absorption of N-acetyl-D-glucosamine and D-glucosamine, their incorpo­
ration into serum and tissue glycoproteins, their conversion into 
other compounds, and their elimination from the body. All studies were 
carried out on intact albino rats.
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CHAPTER II
REVIEW OF THE LITERATDRE
General Chemistry of Glucosamine (2)
The chemical properties of glucosamine are those typical of both 
hexose monosaccharides and primary amines* Glucosamine is a reducing 
sugar and behaves as do neutral hexoses towards alkaline copper and 
silver reagents* Oxidation of the reducing group leads to the formation 
of the corresponding 2-amino gluconic acid* More vigorous oxidation 
results in the loss of the amino group and the formation of a mixture 
of dicarboxylic acids such as oxalic, maleic, etc* Glucosamine is 
susceptible to oxidation by glycol splitting reagents, such as sodium 
metaperiodate and lead tetra acetate* O— and N- derivatives are formed 
with acetylating reagents, and methyl ethers are formed under conditions 
similar to those applied to other hexoses; pyranosides and furanosides 
are known*•
Glucosamine reacts readily with carbonyl compounds to give Schiffs 
bases* N-acyl derivatives are formed when the amino sugar reacts with 
molar proportions of acid chlorides and acid anhydrides in organic 
solvents. Secondary and tertiary bases and quaternary ammonium 
derivatives result from the alkylation of the amino group*. 1-fluoro-
2 ,4-dinitrobenzene condenses with glucosamine to form the DNB
2
3derivative. This reaction is particularly useful in the separation of 
glucosamine from galactosamine and from other sugars by chromatography 
or paper electrophoresis. Oxidative degradation with ninhydrin or 
ch1oramine-T results in the loss of the amino group and decarboxylation 
at carbon number one with the formation of D-arabinose.
A number of relatively specific c o Io t  reactions are used in the 
quantitation of glucosamine. The two of major importance are the 
Elson-Morgan and Dische-Borenfreund tests.
In the Dische-Borenfreund method (3> the 2-aminohexoses are 
deaminated by nitrous acid which leads to the formation of 2,5- 
anhydrosugars. These sugars give a color reaction with indole in the 
presence of HCl. Other sugars also appear to react with indole and 
give values for the amino sugars that are higher than those obtained 
in the Elson-Morgan method. The basis for the Elson-Morgan reaction 
(4) is the condensation of the 2-amino hexose molecule with acetyl- 
acetone in alkaline solution to give pyrroles. The presence of amino 
acids and reducing sugars interfere with the color production. A 
number of modifications of the method (5), (6), (7) have been described 
for the estimation of glucosamine in the presence of proteins and 
protein hydrolysates.
Glucosamine does not give a positive Molisch reaction for 
carbohydrate, nor does it react with any of the acid phenol reagents 
for aldoses.
In aqueous alkaline conditions, glucosamine undergoes a series of 
complex changes, including deamination. It is readily oxidized in the 
presence of air. Deamination is also brought about by condensation
4with phenylhydrasine and by reaction with nitrous acid.
Distribution of Glucosamine 
Glucosamine is found in a wide range of animal species as a 
constituent of the structural substances and biological fluids.
Heparin, a sulfated mucopolysaccharide with marked anticoagulative 
properties, was first isolated in 1916 by McLean (8). Analysis of , 
highly purified heparin (from lung and liver) has shown that the 
principle monosaccharide units are D-glucosamine and D-glucuronic 
acid (9),(10). Hoffman and Meyer (11)'have designated the structure of 
the heparin disaccharide as 0-(2-acetamido-2-deoxy- -D-glucopyranosyl)- 
(1— )4) D-glucuronic acid.
Chitin, an important constituent of the exoskeleton of inverte­
brates, yields equimolar portions of D-glucosamine and acetic acid when 
completely hydrolyzed under acidic conditions (12). Chitin is a 
relatively common constituent of fungi (2). In 1934 Meyer and Palmer 
(13) isolated a mucosubstance from bovine vitreous humor which they 
named hyaluronic acid. Hyaluronic acid is now considered to be 
composed of repeating units of hyalbiuronic acid (H-acetyl-glucosamine
and D-glucuronic acid). The hexosaminidic linkages are /3 (1--^4) and
the glucuronidic linkages are (5 (1— ^3) (11). Substances with properties 
similar to hyaluronic acid have subsequently been isolated from umbili­
cal cord (14), tumor fluids (15), synovial fluid (16), ocular fluids, 
skin, and group A and C hemolytic streptococci (2). Blood group sub­
stances are mucopolysaccharides of high molecular weight and are 
composed of carbohydrates and peptide constituents. Acidic hydrolysis
5of the purified A and O substances of hog gastric mucin results in 
the liberation of L—fucoss, D-glucosamine, D-galactosamine and D- 
galactoae, along with about eleven amino acids (2),
Other mueosubstances reported to contain glucosamine are; 
Submaxillary mucin, gastric mucin, urinary mucin, cervical mucins, 
respiratory mucins, hen egg mueosubstances and frog spawn mucin (2), 
Craig and Uzman reported in 1957 (17) the isolation of a lipopoly- 
saceharide composed of glucose, galactose, glucosamine, fatty acids, 
and neuraminic acid from human liver. Glucosamine and its derivatives 
are also found in components of a wide variety of bacterial and 
fungal products (2).
Proteins containing carbohydrate (glycoproteins) have as their 
sugar constituents, in addition to the neutral sugars mannose, 
galactose, fucose and various derivatives of neuraminic acid, the 
amino sugars glucosamine and galactosamine, usually present in their 
N-acetyl form. N-acetylglucosamine is a major carbohydrate constituent 
of the following glycoproteins; Orosomucoid, fetuin, hapto-globin, 
ceruloplasmin, transferrin, bovine protlurombin, bovine fibrinogen,
7s gamma globulins, 19s gamma globulins, Tam and Horsfall urinary 
glycoprotein, human follicle-stimulating hormone, human chorionic 
gonadotropin, human thryrogiubulin, ovine submaxillary glycoprotein, 
and ovalbumin (18).
The protein bound hexosamine in the serum is elevated in many 
disease states. Boas (19) has demonstrated an increase in serum 
hexosamine levels following myocardial infarctions, surgical operations.
6and an acute attack of gout» In gout, an increase in the alpha- 
globulin hexosamines was shown to account for the observed increase 
in total serum hexosamine. Elevated serum hexosamine levels were 
also noted in rheumatic fever, rheumatoid arthritis, and lupus 
erythematosus. In diseases of the central nervous system, an 
increase of total hexosamine content and protein was found in the 
cerebrospinal fluid of patients with meningitis, progressive paralysis, 
and with brain tumors. Similar increases of hexosamine and protein 
were not found in degenerative vascular and senile conditions, or in 
treated epileptics (20). An increase in serum hexosamine has also 
been demonstrated in patients with diabetes mellitus (21), Wins1er
(22) reports the level of protein bound hexosamine (both glucosamine 
and galactosamine) in normal sera to be 83 + 9 mg, %, Shetlar, et al.
(23) report a somewhat lower value of 71 + 4 mg, %,
Metabolism of Glucosamine 
In efforts to determine whether glucosamine can be utilized 
directly, by animals, various feeding experiments have been carried 
out. In 1929, Ariyama and Takahasi (24) fed glucosamine-HCl to rats 
and found an assimilation of 0,30 gm, per 100 gm. of body weight. 
Catchert and Fabian (2) have reported a slow rate of absorption of 
glucosamine from the intestine. Using sacs of hamster intestine, 
Wilson and Crane (25) were able to show that D-glucosamine is not 
transported across the intestinal wall.
Rats fed a diet supplemented with dried beef fibers which had 
been heated with 15% D-glucosamine showed a marked decrease of growth
7and a mortality of 50% (26), The first deaths occurred at 19 days 
and the livers were abnormal. The addition of 20% D-glucosamine 
to the diet after heating had no effect,
Kent and Whitehouse (2), in their review on amino sugars, state 
that in man glucosamine can apparently be metabolized in amounts up to 
100 mg,/kg., and that larger doses fail to produce hyperglycemia or 
glucosuria even in insulin-treated patients,
Becker and Day (27) fed glucose-l-C^^ and glucosone-l-C^^ to 
rats and found that in those animals fed the labeled glucosone, the 
labeled glucosamine level in the mucoproteins was higher than in 
animals which had been fed glucose. Glucosamine labeled in the 
number one position was isolated from the ovomucoid of eggs after 
feeding chickens glucose-l-C^^ (28).
Spiro (29) injected rats with glucose-l-C^^ and found consider­
able incorporation of the label into the bound glucosamine of the 
liver and serum. There appeared to be very rapid interchange between 
the liver and serum glucosamine. The calculated turnover time for 
glucosamine was 0,8 hour for liver and 2 hours for serum. The liver 
appeared to be the primary site of synthesis of serum glucosamine 
from glucose. The synthesis of the protein-bound glucosamine from 
glucose in the other organs studied, namely, kidney, lung, testes, 
and spleen, was shown to be well below than of the liver.
Other studies (30),(31) have also indicated the presence of enzymes 
in several mammalian tissues which are capable of synthesizing glucos­
amine, Similar enzyme systems have been found in bacteria (32),(33) 
and in fungi (34),
8A number of observations indicate the existence of an alter­
native pathway (other than through glucose) utilizing preformed 
glucosamine in the biosynthesis of hexosamine moieties. Dorfman 
et al, (35) report the direct incorporation of glucosamine labeled 
with and into hyaluronic acid by hemolytic streptococci with­
out previous deamination.
Boas (36) administered D-glucosamine HCl intravenously to rats 
and concluded that it was rapidly distributed in all tissues of the 
body, and that the greatest concentration Increase was in the kidneys, 
liver, and intestines.
Shetlar et al. (37) have shown that the radioactivity from D- 
glucosamine—1-C^^ administered intraperitoneally to rats is found in 
high concentrations in the kidney, liver, spleen, lung, brain, di­
gestive system and blood serum. Over 30% of the administered glucos­
amine was metabolized and converted to carbon dioxide, and 15% was 
excreted in the urine. Examination of tissues which had incorporated 
radioactivity from administered D-glucosamine-l-G^^ had shown that 
the labeled sugar is incorporated without appreciable degradation.
Such studies (38), (39) have been made in serum glycoproteins of 
rats and rabbits. In the serum studies, glucosamine was isolated 
from serum protein hydrolysates with the radioactivity still in the 
number one position, and only negligible amounts of radioactivity were 
found in the neutral sugars. Labeled sialic acid, however, was found. 
In rabbits administered D-glucosamine-l-C^^ intraperitoneally, labeled 
glucosamine was found in liver glycoproteins (40) and liver muco­
polysaccharides (41), No radioactivity was detected in liver glycogen.
9amino acids, extractable lipids or neutral sugars associated with 
protein, Kohn et al, (42) report similar findings on the incorpo­
ration of labeled glucosamine into glycoprotein of rat liver. They 
also found that administered N-acetyl—1-C^^-D—glucosamine was not as 
readily incorporated in glycoproteins as glucosamine and that it was 
rapidly deacetylated.
In in vitro studies of plasma glycoprotein metabolism with per­
fused rat liver, Richmond (43) found that glucosamine was converted to 
sialic acid derivatives at a slightly faster rate initially than to 
glycoprotein N-acetylglucosamine, and that N-acetylglucosamine was a 
poorer precursor of macromolecular N-acetylglucosamine than glucosamine.
Enzymatic Studies on the Metabolism of Glucosamine 
Numerous studies on the metabolism in vitro of D-glucosamine 
have shown that the initial step in its utilization is the conversion 
to D-glucosamine-6-phosphate, This is apparently accomplished by a 
nonspecific hexokinase, Hexokinases, found in extracts of brain, 
liver, kidney, and yeast, are capable of phosphorylating not only 
glucose, but also preformed glucosamine (51),(44), Glucosamine-6- 
phosphate has a low reactivity with phosphoglucomutase (45), and it 
is doubtful if the 6-phosphate is converted to the 1-phosphate by 
this enzyme. The acétylation of glucosamine-6-phosphate has been 
studied in Neurospora crassa (46) and yeast (47), Davidson al, 
have shown that the enzyme concerned is specific for glucosamine-6- 
phosphate (48), The resulting N-acetylglucosamine-6-phosphate can 
then be converted to N-acetylglucosamine—l-phosphate by a mutase (49),
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The reaction of N-acetylglucosamine-l-phosphate with uridine triphos­
phate in the presence of a pyrophosphoryiase to form UDP-N-acetyl- 
glucosamine has been described by Maley and Lardy (50). Glucosamine- 
6-phcsphate can also be deaminated to D-fructose-6-phosphate and 
ammonia (51); however, Malay and McGarrahan (52) have shown in ^  vivo 
experiments with rat liver that the sequence of reactions from glucos­
amine to N-acetylglucosamine-6-phos|>hate, fructose-6-phosphate and 
ammonia is greatly influenced by the free D-glucose concentration of 
the liver, and because of its potent inhibitory effect on the phosphory­
lation of glucosamine, they have proposed another pathway: that of
glucosamine ---^ N-acetylglucosamine --- ^ N-acetylglucosamine-6-
phosphate. They support this hypothesis by the finding in rat liver, 
after the intraportal injection of glucosamine-l-C^^ and N-acetylglucos- 
amine-l-C^^, the primary products N-acetylglucosamine, N-acetylglucos- 
amine -6-phosphate, and a mixture of uridine diphosphate N-acetyl­
glucosamine and uridine diphosphate N-acetylgalactosamine. Little or 
no" radioactivity was detected in the hexoses, hexose phosphates, or 
uridine diphosphate glucose. The glucose content of liver was great 
enough to inhibit the phosphorylation of glucosamine in Most instances.
No information is available on the mechanism of incorporation of DDP- 
N-acetylglucosamine into glycoprotein fractions; nor has it been estab­
lished that the UDP derivative is essental for incorporation. In the 
case of acid mucopolysaccharides, the picture is a little clearer, and 
uridine derivatives of the amino sugars appear to be obligatory for their 
Incorporation into the polysaccharide polymers (53). Stanley ^  al. (54) 
have reported the synthesis of N-acetylglucosaminylribitol linkages
11
in teicholic acid by a particulate enzyme preparation from Staphylo­
coccus aureus.
Besides incorporation into glycoproteins and acid mucopoly­
saccharides, PDF-N-acetylglucosamine has been observed to undergo an 
epimerase reaction to UDP-N-acetylmannosamine and then to sialic acids 
(55), (56), (57), Card ini and Leloir (58-) have described the enzymatic 
epimerization of PDP-N-acetylglucosamine by rat liver to DDP-N-acetyl— 
galactosamine.
The Effect of Glucosamine and N—Acetyl— 
glucosamine on Metabolism 
The.inhibition of glucose metabolism by glucosamine and N-acetyl"- 
glucosamine has been reported by various investigators. Spiro noted 
a pronounced competitive inhibition of glucose conversion to glycogen 
and carbon dioxide, as well as a decrease in-fatty acid synthesis and 
in the calculated glucose phosphorylation by these two amino sugars(59). 
Glucosamine in the presence of insulin produced a significant inhibition 
of glucose-l-C^^ oxidation when it was incubated with segments of rat 
epididymal fat pad (60), N-acetylglucosamine was ineffective in this 
respect. Voss et (61) report that glucosamine inhibits glycolysis
in both Yoshida rat and Ehrlich mouse ascites tumors. In contrast to 
the inhibition of glycolysis by glucosamine and N-acetylglucosamine, 
Kushida (62) reports that N-acetyl-D-glucosamine has no effect on the 
respiration of rat liver slices and that N—acetyl-D-galactosamine 
stimulated the respiration by about 60%.
CHAPTER III
MATERIALS AND METHODS
Radioisotopes
N—acetyl-D-glucosamine-l-C^^ was provided through the courtesy 
of Dr» Domenie lezzoni, Chas, Pfizer and Co«, Brooklyn, New York. 
D-glucosamine-l-G^^, N-acetyl-l-C^^-D-glucosamine and D-glucose-l-C-^ 
were purchased from the New England Nuclear Corporation, Boston, 
Massachusetts. The radiopurity of these compounds was checked by a 
paper chromatography technique. Aqueous samples of the isotopes 
were applied to Whatman No. 1 chromatography paper and developed by 
the descending technique with a n-butanol, pyridine, and 0.1 N HCl 
solvent (5:3:2) (63).
The D-glucosamine-1-C^^ and the N—acetyl-l-C^^-D-glucosamine 
were found to be pure; but the N-acetyl-D—glucosamine-1—C^^ was 
contaminated with glucosamine. This impurity was removed by passing 
a solution of the mixture through a Dowex-50W-Xi2 resin column. The 
pure N-acetyl-D-glucosamine-l-C^^ was washed from the column with water.
Preparation of Feeding Solutions
One molar solutions of D-glucose (Mallinckrodt, DSP), N-acetyl- 
D-glucosamine (Pfizer, DSP), and D-glucosamine-HCl (Calbiochem, A grade) 
were prepared in distilled water. Although the hydrochloride form of
12
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glucosamine was used, the solution was prepared so as to be one molar 
with respect to glucosamine. These solutions were checked by the 
paper chromatographic technique described for the labeled compounds 
and no impurities were found.
On the day of the experiment, 15 ml, of the appropriate one-molar 
sugar solution were added to a weighed aliquot of the tracer to be 
used. The specific activities of the tracers were high enough so 
that the molarity of the final solutions was not appreciably changed. 
The maximum amount of tracer added was 15 mg, in 15 ml. The final 
solutions contained 5 microcuries of isotope per ml, for the N-acetyl- 
1-C^^-3-glucosamine, D-glucose-l-C^^, and D-glueoaamine-l-C^^ prepa­
rations. The N-acetyl-D-glucosamine-l-C^^ solution contained 2,5 
microcuries of isotope per ml.
Experimental Animals 
Young Holtzman male rats weighing approximately 100 gm, were 
used. Twenty-four hours prior to the experiment, the animals were 
fasted and provided with water only. The fasting period was generally 
long enough to provide a relatively empty intestinal tract.
Neomycin Sulfate Treatment 
In some cases the rats were treated with neomycin sulfate 
(Nutritional Biochemical Corp.) for two days. The antibiotic was 
supplied in the drinking water at a concentration of 0,5%, The 
animals were allowed food on the first day and then fasted the final 
24 hours prior to the experiment. At the end of the neomycin treatment 
period, rectal swabs were made and streaked on desoxycholate agar.
14
At the end of 72 hours, only an occasional calony of E, coll. could 
be found on the cultures fr<sa the treated rats. In the case of the 
untreated animals, a heavy growth of E, coll was obtained.
Insulin Treatment 
Some of the animals were treated with insulin prior to the 
experiment. The fasted animals were Injected subcutaneouly with 
1.0 unit/kilogram body weight of insulin (Lilly, ÜSP Iletin) 30 min­
utes before the beginning of the experiment. Although this dosage 
caused the animals to appear sluggish and drowsy. It did not produce 
a condition of shock,
Phlorizidin Treatment 
Another group of animals was poisoned with phlorizidin by the 
method of Bogdanova and Barker (64). Prior to the experiment, the 
animals were given five 0.25 ml, subcutaneous Injections of 10% 
phlorizidin dihydrate (Calbiochem) in sesame oil at Intervals of 
12 hours. This treatment was in addition to the routine 24 hour 
fasting period. At the end of the phlorizidin treatment all animals 
exhibited a copious glycosuria.
In some groups of animals there was a combination of neomycin 
and insulin treatment or neomycin and phlorizidin treatments.
Feeding of Animals 
After the pretreatment and/or fasting period, the animals were 
weighed and divided Into groups of 9 each. Each group was then fed 
by stomach tube 1 ml. of the 1 M sugar solution to be Investigated,
15
The device used to feed the animals was fashioned from a tuberculin 
syringe fitted with a blunt nosed 20 gauge needle over the hub of which 
had been slipped a No. 8 urinary rubber catheter. The inside diameter 
of the catheter was small enough so that capillary action prevented 
the solution from draining after the device was filled. This assembly 
was fitted into a lock device which insured a constant filling of the 
syringe and catheter when the plunger was retracted to its maximum 
preset limit. The constancy of delivery of this feeding device was 
determined and the average error was found to be 0.82 per cent in a 
series of 9 on a 1 ml, delivery.
One ml, of each feeding solution was emptied from the feeding 
device into a volumetric flask and diluted to 200 ml, with water.
The radioactivity found in this solution was used as the base line 
for the calculations of absorption.
Immediately after feeding, the animals were divided into groups 
of three and placed in Roth metabolism cages (65) where they had free 
access to water. They were maintained in the cages for 3 hours during 
which time urine was collected and expired carbon dioxide was trapped 
in a gas washing tower containing either 130 ml of 3M NaOH or 100 ml, 
of a mixture of monoethano1amine and ethylene glycol monoethyl ether 
(1:2 v/v) (66), NaOH was used to trap the carbon dioxide for the 
untreated animals fed D-glucosamine-l-C^^; the organic mixture was 
used for all other experiments. Both methods are equally efficient 
in trapping carbon dioxide, but the subsequent determination of radio­
active carbon dioxide is much easier with the organic~solvent mixture.
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Sacrifice of the Animals and Recovery 
of the Intestinal Contents 
After the three-hour period in the metabolism cages, the animals 
were anesthesized with ether and exsanguinated through the abdominal 
aorta. The gastrointestinal tract was clamped off with hemostats at 
its upper and lower extremities, gently pulled loose from the mesentary 
and placed in a beaker where it was slit longitudinally and thoroughly 
washed with water. The washings, intestinal contents, and instrument 
rinsings were transferred to a Waring blendor and homogenized. The 
homogenate was made up to 200 ml. with water and layered with toluene. 
An aliquot of this mixture was then centrifuged at 35,000 x g for 
1 hour at -50 C, An aliquot of the resulting clear supernatant was 
then processed immediately for radioactivity determinations and the 
remainder stored at -20° C.
The liver was perfused with ice cold 0.85% saline and lyophilized. 
The washed gastrointestinal tract (stomach, small intestine, and large 
intestine) was lyophilized.
Studies of Serum Proteins 
Blood collected from the animals was allowed to clot at room 
temperature, and the serum was obtained by centrifugation.
Total serum radioactivity was determined after incubating 0.050 ml, 
of serum with 1.0 ml. of Hyamine Hydroxide (diisobutyl cresocyethoxy- 
ethyl dimethylbenzylammonium hydroxide. Pilot: Chemicals, Inc.) in 
capped scintillation vials (Nuclear Chicago Corp.) in an oven at 40°- 
50° C for 4 hours. Fifteen ml. of standard scintillation solution
17
were added (4 g. 2j5-diphenyloxazole and 50 mg. 154-bis-2-(5-phenyl- 
oxazolyD-benzene, Nuclear Chicago Corp. ) per 1000 ml, spectro quality 
toluene, (Matheson, Coleman and Bell). To effect solution of the 
Hyamine-serum complex in the toluene, 1,0 ml, absolute ethanol was 
added to the scintillation solution. This mixture was then counted 
in a Nuclear Chicago Corp, 725 room temperature liquid scintillation 
system. Results were expressed as c/m per mg, protein. Protein was 
determined by the biuret method.
Protein bound radioactivity was determined by dialyzing 0.20 ml, 
of serum in Visking casing against running tap water at 8° C for 72 
hours. The dialyzed serum was diluted to 5,0 ml, and 1,0 ml. of this 
solution was pipetted into scintillation vials, taken to dryness, and 
then heated with 1,0 ml. Hyamine as before. The determination of radio­
activity was as previously described. The results were also expressed 
as c/m per mg, protein.
Tissue Studies
The dried tissues (liver and small intestine) were ground in a 
Wiley mill to pass through a 60-mesh screen. Solutions of tissue 
for total radioactivity were made by heating aliquots (4 to 30 mg.) 
of the ground, dried tissue with 1,0 ml, Hyamine and 0.1 ml, water 
in capped scintillation vials at 40°-50° c for & hours. Fifteen 
ml, of the standard scintillation solution and 1,0 ml, ethanol was 
added to the samples and they were then counted as previously 
described. The activity was expressed as c/m per mg, dry tissue.
Bound radioactivity of the tissues was determined after dialysis
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of hcmogeïiates of ground dry tissue in tap water» Two ml. of the 
homogenates were pipetted into Visking casings and dialyzed against 
running tap water at 8° C for 72 hours. Two ml. aliquots of the 
dialyzed material were pipetted into weighed scintillation vials and 
taken to dryness. The vials and their contents were then weighed and 
the weight of the tissue determined by difference. The procedure for 
counting the dialyzed tissues was the same as described for the non- 
dialyzed tissue. The radioactivity was expressed as c/m per mg, dry 
tissue.
Déterminât ion of Radioactivity in Intestinal Contents.
Feeding Solutions, and Expired COg 
0,020 ml, of the diluted feeding solutions and intestinal contents 
were pipetted into scintillation vials, 3,0 ml, absolute ethanol and 
15 ml, of standard scintillation solution were added, and the radio­
activity measured. Radioactivity was expressed as c/m per ml, for the 
feeding solutions and as total c/m washed from the gastrointestinal 
tract for the intestinal washings.
Radioactivity in the expired carbon dioxide, in the cases where 
the organic solvent mixture was used as the trapping agent, was 
determined by pipetting 3,0 ml, of the COg-amine complex into scintil­
lation vials and adding 15 ml, of scintillation solution composed of 
toluene, ethylene glycolmonomethyl ether (2:1 v/v), and 5.5 gm.
2,5-diphenyloxazoIe per 1000 ml. of solution. Samples were counted 
as previously described and the radioactivity was expressed as total 
c/m expired in 3 hours.
In the experiment in which NaOH was used to trap the COg,
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sliquots of the HaOK solution were mixed with an excess of saturated 
BaClg* The precipitated BaCO^ was washed with water and suspended 
in absolute ethanol. An aliquot of the suspension was plated on 
concentric stainless steel planchets (Atomic Accessories), dried, and 
the radioactivity determined in a Nuclear Chicago gas flow counting 
system. Corrections were made for self-absorption of the sample and 
machine efficiency so that the determined c/m expired could be adjusted 
to absolute counts. This data may then be compared directly with that 
obtained with the liquid scintillation system.
Identification of Radioactive Compounds 
Samples of the dialyzed tissues (serum, liver and small intestine)
were prepared by pooling aliquots from within each experimental group.
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These samples were hydrolysed in two systems, one designed to liberate 
amino acid and amino sugars, and a less rigorous one which liberates 
neutral sugars. For the amino acid and amino sugar studies of the 
tissues and serum, samples (10-20 mg.) were hydrolyzed in 4 ml. of 
6 N HCÎ at 100° C in closed tubes for 20 hours. For neutral sugar 
studies, the samples were hydrolyzed in 2 N HCl at 100° C in closed 
tubes for 18 hours. The hydrolysates were then decolorized with 
Norite A and taken to dryness under vacuum over CaSO^ or silica gel 
and NaOH pellets.
To effect the separation of neutral sugars, amino sugars and 
amino acids, the dried hydrolysate residues were dissolved in 0.5 ml. 
of water and chromatographed on a 1 x 6.5 cm. column of Dowe% 50X12, 
100-200 mesh resin in the hydrogen form. Neutral sugars were washed
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from the column with 20 mi. of water, hesosamines were eluted with 
30 ml, of 0,3 N HCl and the amino acids with 20 ml, of 4 N HCl,
These fractions were taken to dryness by the same procedure used for 
the original hydrolysates and the residues dissolved in 0,5 ml, water, 
0,20 ml, of these solutions were pipetted into scintillation vials, 
mixed with 30 ml, absolute ethanol and 15 ml, of the standard scintil­
lation solution and counted, 0.03 ml, of the remaining solution were 
applied to Whatman No, 1 chromatography papers and the chromatograms 
developed in an n-butanol, pyridine, 0,1 N HCl (5%3;2) system. Amino 
acids <fere detected by dipping the chromatograms in 0,2% ninhydrin in 
a 1% solution of glacial acetic in acetone, Hexoses were detected by 
dipping the chromatograms in a solution of 0-aminobiphenyl (5% amino- 
biphenyl in a 1,3% solution of phosphoric acid in glacial acetic acid), 
and then heating at 100-110° C for 2-5 minutes. The amino sugars 
were detected with both color developing reagents.
The intestinal contents were, not hydrolyzed prior to application 
to the column because even mild acid hydrolysis destroys N-acetyl- 
glucosamine. In addition to hexoses, N-acetylglucosamine is present 
in the water eluant.
Radioactive sugars in the urine were detected after applying 
0,005 ml, aliquots to Whatman No, 1 paper and developing the chromato­
gram in the butanoI-pyridine-HCl solvent. The sugars were located 
with the aminobiphenyl reagent. The radioactivity of these spots was 
detected by cutting them out, placing them in scintillation vials with 
7 ml, of the standard scintillation solution and counting them for 20 
minutes.
Correction of Observed Counts 
for Quenching
All counts obtained with the liquid scintillation counter, with 
the exception of those from the paper chromatogram spots, were corrected 
for quenching by the channels ratio method (67), (68). This method was 
found to give results identical to those obtained by internal stand­
ardization for all samples with the exception of the liver tissues. For 
these tissues a special efficiency to ratio curve was constructed from 
nonradioactive liver and added
Statistical Methods
With the exception of the paper chromatogram spots, all samples 
were counted until a total count of at least 10,000 was obtained.
The per cent error is 2.00 at the 96% confidence level for this 
total number of counts.
Data were compared statistically by the ”t" test as applied 
to the means of small samples (69) using the formula
Xi - %2
t  =   :_____________________________________________   :_____________
wnere x^ and X2 represent tne means or two groups, and 
number in each group, and Sj and S2 , the respective standard
deviation.
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In the following discussion, differences are considered to 
be significant only where the calculated probability values are 
equal to or less than 0*01.
CHAPTER IV
RESULTS AND DISCUSSION
Absorption of D-Glncosamlne and H-Acetyl-D-Glucosamtne 
In 1925, Carl F. Cori (1) published a method for the quantitative 
study of absorption from the whole intestinal tract of the rat. The 
animals were fed a known amount of the substance under investigation 
by a stomach tube* After a given time, the rats were killed and the 
amount of substance remaining in the intestines was determined quanti­
tatively* The difference between the amount fed and the amount re­
covered from the whole intestinal tract was considered as the amount of 
substance absorbed. He proposed that the amount of a given substance 
that is absorbed should be proportional to the absorbing surface of 
the intestinal tract, and that, since the surface of the intestine 
will vary with body weight, larger animals will absorb more than 
smaller ones* He showed that the ratio of the amount absorbed to 
body weight was a constant. He was careful to point out, however, 
that this proportionality between the amount absorbed and the body 
weight was found in rats that were still in a period of active growth, 
and that it might not be valid for fully grown rats where variations 
in depot fat and other factors might play a role. In addition to the 
relationship between absorption and body weight, he was able to show
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that, when the amount of sugar that is absorbed per 100 gm. of body 
weight is plotted against time, a straight line relationship is 
obtained. On the basis of these experiments utilizing the sugars 
glucose, galactose, fructose, mannose, xylose and arabinose, he 
formulated the following equation for calculating absorption co­
efficients (C), the amount of a given substance absorbed per 100 
gm. of body weight in one hour;
C = A X 100 
W X T
where A is the total amount of substance absorbed in a given period,
W is the weight in grams of the rat after fasting for 48 hours and 
T is the length of the period in hours.
Cori found that the rate of absorption was not affected by the 
concentration or amount of sugar fed; however, a hypertonic sugar 
solution was diluted in the stomach. Other workers, using Cori's 
technique for studying sugar absorption, have published results 
which are at variance with those of Cori. Cori's conclusion that 
the rate of absorption of glucose was not influenced by variations 
in the concentration of the administered solution has been questioned. 
Macleod et al. (70) concluded that absorption was greatest from a 
13.5 per cent glucose solution, and MacKay and Bergman (71) have 
reported that the absorption rate is influenced by the concentrations 
of the administered solutions. The conclusion that the rate of absorp­
tion is constant has been objected to by Pierce et al. (72) and by 
Feyder and Pierce (73), who have shown a decreased rate of absorption 
during the second and third hours of the absorption period. In
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similar investigations, Fenton (74) was led to conclude that absorption 
from the intestine of the intact animal increased significantly as the 
concentration of the solution which was fed increased, and that the 
rate of absorption, as well as the absorption coefficient, decreased 
with time, Fenton also reported a nonlinear relationship between body 
weight and absorption; however, he also found that the absorption was 
not entirely independent of body weight.
In the investigations reported here, it was of interest not only 
to obtain Information concerning the absoption of D-glucosamine and 
N-acetyl-D-glucosamine in the intact rat, but also to determine the 
fate of these amino sugars after they were absorbed. For these 
reasons, the basic technique as described by Cori (1), even though 
it appears not to give the best estimates of absorption rates, was 
chosen.
An attempt has been made to limit as many variables as possible 
in these studies. All animals were approximately the same age and 
body weight and were males of the Holtzman strain. The sugar solutions 
fed were the same molar concentrations. The majoritity of other studies 
of absorption have been made with sugar solutions whose concentrations 
have been expressed as percentages. It is felt that, regardless of 
the mechanism of movement of the sugars from the mucosal to the 
serosal side of the intestine, i.e., whether an active transport 
mechanism or a simple diffusion process is in operation, a more 
realistic approach to the problem of sugar concentration would be to 
make comparisons of absorption only when the sugars are present at
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initially equal molar concentrations. The period of absorption was 
3 hours in every case. This time period was chosen not only for ease 
in handling several animals over a staggered period of time, but also 
because, at intervals longer than 3 hours, the animals fed the amino 
sugars exhibited diarrhea.
Cori and other workers have used colorimetric copper reduction 
methods to determine the amount of sugar remaining in the intestine 
after the absorption period. These methods are not only tedious, 
but also have the disadvantage that substances may be present in the 
intestinal contents which interfere with the colorimetric determin­
ations. In the absorption studies reported here, the amount of sugar 
absorbed was determined by the Isotope dilution technique. From the 
amount of radioactivity associated with the initial sugar concen­
tration of the feeding solution and the amount of radioactivity 
recovered in the intestinal washings, the amount of sugar absorbed 
can be calculated by simple ratio and proportion. This technique is 
valid only if there is no degradation of the labeled sugar while it 
is in the lumen of the intestine. To investigate the possibility of 
such degradation, aliquots of the intestinal contents from the animals 
fed D-glucosamine-l-cl4 and N-acetyl-D-glucosamine-l-C^^, and also 
aliquots of intestinal contents from animals fed the same labeled 
sugars but treated with the antibiotic neomycin, were concentrated 
and chromatographed on Whatman No. 1 paper in a n-butanol, pyridine, 
0,1 N HCl solvent system (5:3:2). The radioactivity associated with 
the chromatographically isolated compounds, is given in Table 1. The 
only appreciable radioactivity was found associated with the original
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radioactive sugar. This would appear to indicate that there is no 
destruction of the sugars tested in the intestine. However, this 
conclusion is not entirely valid since a conversion of glucosamine 
to a more readily metabolizable compound, such as fructose, might 
provide a hexose which could easily pass through the intestinal wall 
and would not be detected by the procedure. Data will be presented 
later which indicate that there is probably some destruction of the 
glucosamine molecule by the intestinal flora. It is significant, 
however, that no glucosamine was found in the intestinal contents of 
the animals that were fed N-acetylglucosamine, This provides direct 
evidence that the acetylglucosamine molecule is not appreciably de- 
acetylated before leaving the lumen& Cori (1) investigated the 
possibility of loss of glucose from the intestine due to bacterial 
action, and found that the loss was so small that it could be ne­
glected.
Using a combination of Cori's technique and the radioisotope 
dilution technique, the absorption coefficients for D-glucosamine 
and N-acetyl-D-glucosamine were determined. These results (Table 2) 
indicate that both .glucosamine and N-acetylglucosamine are absorbed 
at approximately the same rate, and that this rate of absorption is 
much slower than the absorption rate for glucose. These results are 
in agreement with the hypothesis of Crane (25) which predicts the 
characteristics a sugar molecule must have in order to be actively 
absorbed by the intestine, i.e., the compound must possess a D- 
pyranose structure, a methyl or substituted methyl group at carbon 
five of this structure, and a hydroxyl group in the glucose configu-
ration at carbon two. It is readily apparent that both glucosamine 
and N-acetylglucosamine meet this criteria with the exception of the 
hydroxyl group in the glucose configuration at carbon two. It is 
not the purpose of this investigation to determine the mechanism of 
transport of the amino sugars across the intestinal wall.
It should be mentioned that the data given for the absorption 
of glucose is misleading in that it indicates that only one millimole 
of glucose is absorbed in a 3-hour period. Almost identical values 
(Table 3) were obtained for 1-hour absorption periods. It is indi­
cated then that an animal fed 1 ml. of 1 M glucose (0.18 gm. glucose) 
is able to completely absorb this amount in at least one hour. This 
is in agreement with Cori (1) who gives a value of 0.178 gm. glucose 
absorbed per 100 gm. body weight pgr hour. The absorption data for 
glucose (Table 2) is included only for the purpose of contrasting 
the absorption rate of an actively transported sugar and the amino 
sugars.
There is a significant difference in the absorption of glucos­
amine in animals which have had their intestinal flora diminished by 
neomycin treatment and in untreated animals (Table 2). The decrease 
in the absorption rate in the treated animals could possibly be due 
to an inhibition by the neomycin.
It is to be noted that there is no difference in the absorption 
rate of N-acetyl-D-glucosamine as determined by isotope dilution with 
the acetylhexosamine molecule labeled in either the acetyl moiety or 
the glucosamine moiety (Table 2), This data, together with that from 
the chromatograms of the intestinal contents of rats fed N-acetyl-D-
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g l u c o s a m i n e - 1 ( T a b l e  1), lead to the conclusion that N-acetyl— 
glucosamine Is absorbed from the lumen without degradation. This Is 
perhaps significant in that the majority of the naturally occurring 
forms of glucosamine, as found in tissue glycoproteins and mucopoly­
saccharides, is N-acetylglucosamine. It is possible, therefore, that 
an animal may utilize a dietary source of N-acetyl-D-glucosamine to 
supplement the de novo synthesis of acetylglucosamine compounds in 
the body.
Metabolism of Absorbed D-Glucosamine 
and N-Acetyl-D-Glucosamine 
Having established that D-glucosamine and N-acetyl-D-glucosamine 
are absorbed from the intestine, it was of interest to follow the 
metabolism of these compounds in the living animal.
At the end of the 3-hour period, 10% of the absorbed radio­
activity had been expired as COg in the animals treated with neomycin 
and fed N-acetyl-D-glucosamine-l-C^^ (Table 7). Essentially similar 
results were found in the untreated animals fed N-acetyl-D-glucosamine- 
1-CÏ4, There was a large difference in the per cent absorbed radio­
activity expired as GOg in the treated and untreated animals fed glucos- 
amine-l-C^^ (4.5% for the neomycin treated animals and 17.9% for the 
untreated animals>. This is a further indication that in animals not 
treated with neomycin glucosamine is degraded in the lumen of the 
intestine by microorganisms.
An appreciable amount of radioactivity from absorbed D-glucosamine= 
l-C^* and N-acetyl-D-glucosamine-l-C^^ was found in the body tissues^
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Radioactivity was also found in tissues of animals fed glucose—1-C^^« 
In the tables referred to below which show the distribution of radio­
activity in the tissues, the data in the columns headed "Percentage 
Absorbed Radioactivity in ---" (serum, liver or small intestine) are 
the percentage of the radioactivity that was absorbed from the in­
testine and found to be present in the entire tissue under investi­
gation, This value then is based upon the total radioactivity in 
the particular tissue and represents both "bound" and "unbound" 
radioactivity. The data in the columns headed "Percentage Non- 
Dialyzable Radioactivity in —— “ (serum, liver or small intestine) 
is the percentage of the radioactivity in a tissue (c/m per mg.) 
which remains after dialysis of the tissue against running tap water 
for 72 hours.
In the animals treated with neomycin and then fed D-glucosamine— 
1-C^^, 2.0% of the absorbed radioactivity was in the serum (Table 4), 
7.1% of the absorbed radioactivity was in the liver (Table 5), and 
12-4% was in the walls of the small intestine (Table 6). The 
relatively high values for the percentage absorbed radioactivity in 
the liver and the percentage nondialyzable radioactivity in the liver 
of the animals fed D-giucose-l-C^^ as ccapared to those fed D-glucos- 
amine-l-C^^ or K—acetyl-D-glucosamine-l—C^^ probably reflects the 
conversion of the absorbed glucose to glycogen. Other investigators 
have reported (39), (40),(42) that intraperitoneally injected glucos­
amine is not converted to glycogen, and the data in Table 5 indicate 
that glucosamine or N-acetylglucosamine which is absorbed from the 
intestine is also not readily converted to glycogen. Results in
31
Tables 4, 5, and 6 also show that in the animals fed D-glucosamine- 
1-C^^, 53.2% of the radioactivity in the serum was nondialyzable or 
"bound" (presumably to serum protein); 16,2% of the radioactivity in 
the liver was nondialyzable and 23.2% of the radioactivity in the 
small intestine tissue was nondialyzable. These results are in agree­
ment with those of others (37), (38), (39), (42), (43), who have reported 
D-glucosamine-l-C^^ to be efficiently incorporated into plasma proteins 
and tissues.
In animals treated with neomycin and then fed N-acetyl-D-glucos- 
amine-l-C^^, 1,4% of the absorbed radioactivity was found in the serum 
at the end of the 3 hour absorption period, and 19.7% of the radio­
activity there was nondialyzable (Table 4); 2.2% of the radioactivity 
was in the liver, and 37.3% of the liver radioactivity was nondialyzable 
(Table 5), The small intestine tissue contained 8.7% of the radio­
activity absorbed from the intestine, and 28,6% of its radioactivity 
was nondialyzable.
In the animals treated with neomycin and then fed glucosamine, 
the radioactivity which was absorbed from the intestine and present 
in the serum was significantly higher than similarly treated animals 
fed N-acetyl—D-glucosamine-l-C^^. The data for the percentage of the 
radioactivity in the serum and tissues which was nondialyzable indicate 
that there also was significantly greater binding of the label in the 
serum of the neomycin treated and glucosamine-l-C^^ fed animals. How­
ever, the amount of label bound in the liver was significantly less 
than in those animals treated similarly and fed N-acetyl-D-glucosamine- 
There appeared to be no difference in the percentage of the
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absorbed radioactivity found in the small intestine tissue of the 
animals fed 1-C^^ labeled glucosamine or N-acetylglucosamine, or 
in the percentages of the nondialyzable radioactivity there.
It was demonstrated that there was no difference in the rate 
of absorption of N-acetyl-D-glucosamine-1-C^^ and N-acetyl-l-C^^- 
D-glucosamine in the animals treated with neomycin and in those 
which were not. This indicates that no deacetylation of N-acetyl­
glucosamine occurred in the lumen of the intestine. There was the 
possibility, however, that N-acetylglucosamine was deacetylated after 
leaving the lumen of the intestine. If this were to occur to any 
appreciable extent, it might be expected that the glucosamine formed 
would spill over into the urine; however, no glucosamine was found 
in the urine of animals fed N-acetylglucosamine. Glucosamine was 
detected in the urine in the experiments in which an equivalent amount 
of glucosamine was absorbed (Table 14). The kidney has been reported 
to have a very low threshold for glucosamine (75), and radioactive 
glucosamine has been reported to be present in the urine of rats after 
parental injections of tracer amounts of g l u c o s a m i n e - 1 (42). 
Glucosamine was not detected on paper chromatograms of the urine from 
animals fed N-acetyl-l-C^^-glucosamine or N-acetylglucosamine-1-C^^, 
nor was any radioactivity detected in the area of glucosamine mobility 
(Table 13). The data in Table 7 indicate an increase in the percentage 
absorbed radioactivity expired as COg for the animals fed the N-acetyl- 
labeled glucosamine (29.9%) as compared to the N-acetylglucosamine- 
1-C^* fed animals (10.1%). This would mean that approximately 0.08 
millimoles of acetylglucosamine had been deacetylated or, stated
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another vay, 0,08 millimoles of glucosamine (14.4 mg.) had been 
produced. This amount was in excess of the 4,5 mg. of glucosamine- 
l-cl4 tracer injected by Shetler et al, (37) in the experiment in 
which they reported finding radioactivity (glucosamine) in the urine. 
There was no apparent explanation for the absence of labeled glucos­
amine in the urine of animals fed N-acetylglucosamine-l-cl4. however, 
N-acetylglucosamine is absorbed at a slow rate from the intestine 
and it is possible that the free glucosamine formed would be metabo­
lized before accumulating to s serum level high enough to spill over 
into the urine, __
If deacetylation of the acetyl-labeled hexosamine molecule does 
occur in the animal body, it might be expected that the distribution 
of the label in the tissues would differ from that obtained with the 
hexoamine-labeled molecule. The only significant difference detected 
was in the percentage of nondialyzable radioactivity in the small 
intestine tissue (Tables 4, 5, and 6). The acetyl-labeled hexos­
amine produced a greater percentage of bound radioactivity in the 
small intestine and this is perhaps a reflection of the incorporation 
of the acetate moiety into lipid material.
The data presented do not give a clear picture as to the fate of 
the acetyl moiety of absorbed N-acetylglucosamine. There was evidence 
that the molecule was deacetylated as indicated by the increased per­
centage of the label in the expired CO2 as compared to the percentage 
expired when N-acetylglucosamine-l-Cl4 was fed. However, the deacetyl­
ation reaction does not. appear to be extensive since no glucosamine was 
found in the urine. Kohn et al. (42), in studies made with parenterally
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injected (3 microcuries) N—acetyl—1-G^^—glucosamine and sodium 
acetate-l-C^^, reported the recovery of 38,3% of the isotope in CO2 
in the case of administered N-acetyl-l-C^^-glucosamine, and 54,5% 
in CO2 from administered sodium acetate. There was a small percentage 
of labeling, frcm both compounds, of liver lipids. They interpreted 
these results as indicating a rapid deacetylation process for N- 
acetylglucosamine. However, no information was given concerning the 
amount of sodium acetate or acetylglucosamine injected, and no con­
sideration was made of the effect of dilution on the injected isotopes 
by the acetate and acetylglucosamine pools.
It has been established by short term experiments vivo (39), 
(40) and in vitro (30), (43) with glucossaine-l-cl^ that this compound 
in addition to being readily incorporated into tissue glycoproteins 
and muco-substances, was not appreciably degraded in the animal. To 
investigate the possibility that enzymic reactions in the tissues of 
the small Intestine could degrade absorbed glucosamine and N-acetyl- 
glucosamine, samples of dialyzed serum, and liver and small intestine 
tissue were hydrolyzed in 6 H HCl,, and the hydrolysates fractionated 
on Dowex 50 columns into hexosamine and amino acid components. The 
radioactivity of each fraction was determined. Under ideal conditions 
only hexosamine8 are eluted with 0,3 B HCl and amino acids are eluted 
with 4 N HCl, However, it was demonstrated by paper chromatography 
that the 0,3 N HCl fraction was contaminated by traces of amino acids. 
No contamination of the 4 N HCl fraction by hexosamines was detected. 
Although the vigorous hydrolysis in 6 K HCl destroys almost completely
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the neutral sugars and a portion oË the hexosamlnes, this extreme 
condition was necessary in order to effect a nearly complete hydrolysis 
of the tissues so that contamination of the fractions by peptides was 
minimal. For this reason, the radioactivity detected in the hexos­
amine fraction from the column was lower than would have been detected 
if the hexosamine moieties in the tissues had been liberated without 
partial destruction, A more gentle hydrolysis of the tissues in 2 N 
HCl made it possible to identify the neutral sugar components by 
paper chromatography. Glucose, mannose, and galactose were detected 
in the hydrolysates of liver and the small intestine, and mannose and 
galactose were detected in the serum hydrolysates. If these sugars 
contained carbon-14, their specific activity was not high enough to 
be detected by the usual procedures.
Although not strictly quantitative because of the partial 
destruction of hexosamine during hydrolysis, the data presented in 
Table 15 indicate that a majority of the glucosamine absorbed from 
the intestine was incorporated without degradation of the carbon 
chain into héxosamine-containing substances of the tissues investi­
gated. A greater percentage of the radioactivity in the hydrolysates 
of tissues from animals not treated with neomycin was in the amino 
acid fraction than in those animals which were treated with neomycin. 
These results are a further indication that glucosamine was degraded 
by the intestinal flora. Neomycin treatment does not seem to be a 
factor in the incorporation into serum and tissue amino acids of 
carbon-14 from K-acetylglucosamine-l-C^^ fed animals. As in the
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case of the gluccsamine-l-C^^ fed animals, both hexosamines and amino 
acids appear to be labeled.
The Effect of Phlorizidin and Insulin on the Absorption and 
Metabolism of D-Glucosamine and H-Acety1-D-Glucosamine 
It has been demonstrated that under the conditions described 
for these investigations absorbed glucosamine was more efficiently 
incorporated into the hexosamine-containing components of the body 
than was absorbed N-acetylglucosamine» It is possible that N- 
acetylglucosamine does not penetrate t^e cell membranes and, as a 
result, is not available to the enzymatic mechanisms responsible 
for the incorporation of hexosamine into glycoproteins and muco- 
substances. It may also be that preformed N-acetylglucosamine is 
not readily phosphorylated in the cell, although McGarrahan and Maley 
(53) have demonstrated that N-acetylglucosamine is readily phosphory­
lated, in the absence of glucose, by rat liver.
The mechanisms of action of insulin are still somewhat obscure, 
but it appears that insulin is involved in: the transfer of certain
sugars across cell membranes, the formation of hexose-6-phosphate 
and the regeneration of adenosine triphosphate (76). Phlorizidin 
has been demonstrated to produce glycosuria, inhibit the phosphory­
lation of hexose and the absorption of glucose, mannose, and galactose 
from the intestine (76). The action of phlorizidin and insulin on 
the absorption and metabolism of glucosamine and N-acetylglucosamine 
was investigated. Since it has been shown that glucosamine was 
degraded by the intestinal flora, only animals that had been treated
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with neomycin were need.
Treatment of the animals with insulin produced no change in 
the rate of absorption when glucoaamine-l-Cl^ was fed; however, 
the amount of carbon-14 in the CO2 expired almost doubled with insulin 
treatment (Table 11). A slight increase was also detected in the 
amount of radioactivity expired in the CÔ2 from the N-acetylglucosamine- 
1-CÏ4 fed animals; however, no change in absorption was detected, 
Phlorizidin increased significantly the rate of absorption of glucos­
amine and decreased slightly the radioactivity expired as C02. The 
effect of phlorizidin on the absorption of K-acetylglueosamine was 
quite pronounced. The absorption coefficient decreased from 0.068 
to 0.026 after treatment with phlorlzinlm, and a slight increase in 
the percentage of absorbed radioactivity expired as CO2 was found 
(Table 11).
The effects of insulin and phlorizidin treatment on the incorpo­
ration of radioactivity from absorbed glucosamine-l-C^^ and N-aeetyl- 
‘glucosamine-l-C^^ into the liver, aerum and small Intestine tissue 
as compared to incorporation in untreated animals are summarized in 
Tables 8, 9, and 10. Insulin produced no significant effect on the 
incorporation into tissues of radioactivity from D-glucosamine-l-C^^ 
fed animals. Insulin was also ineffective on the incorporation of 
radioactivity into the tissues of 8-acetyl-D-glucosamine-l-C^^ fed 
animals.
The effect of insulin in increasing oxidation of the carbon—14 
labeled sugars was similar to its effect on glucose oxidation (Table 11),
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and suggests that insulin facilitates the entry of these amino sugars 
into the cell. There was a slight increase in the percentage of non­
dialyzable radioactivity in the serum, liver and small intestine tissues, 
but the differences were not significant at the 1% probability level,
Wick et al, (77) have reported that insulin greatly enhances the ent­
rance of glucosamine into the muscle cells of eviscerated rabbits. Their 
experimental conditions differed from those described in this investi­
gation in that they gave the animals a maximal amount of insulin (20 
units per kilogram), which necessitated the maintainence of the animal 
by glucose infusions, and they made a single injection of glucosamine.
The findings that insulin had no significant effect on either the total 
amount of glucosamine in the tissues or Œi the amount bound in the 
tissues, but did increase the oxidation of glucosamine to carbon di­
oxide (and perhaps accounts for the lack uf increase in the total amount 
in the tissues), suggests that accessibility to the interior of the 
cell is not a factor in the incorporation of glucosamine into hexosamine- 
containing substances of the tissues. The lack of effect of insulin on 
the absorption coefficient for glucosamine, in view of its enhancement 
of cell permeability to glucosamine, suggests that the same mechanisms 
are not involved in moving glucosamine across the intestinal walls as 
are involved in moving glucosamine^ into the cells. A similar argument 
may be proposed for the action of insulin on the metabolism of absorbed 
N-acetylglucosamine, The lack of effect on the rates of absorption of 
glucosamine and N-acetylglucosamine by insulin suggests that these 
sugars were not transported across the intestinal wall by a mechanism
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similar to that for glucose and galactose.
The effect of phlorizidin treatment on the incorporation of 
radioactivity from D-glucosamine-l-C^^ into tissues was to signifi­
cantly decrease the total radioactivity in the serum and liver and 
to significantly increase the bound activity in the serum.
The increase in absorption of glucosamine and the increase in 
bound activity in the serum of animals treated with phlorizidin and 
fed glucosamine-l-Cl4 could possibly be explained by the following. 
Hexokinases have been described which phosphorylate both glucose and 
glucosamine (31), (32), (33), (34); it is, however, possible that a 
different enzyme is responsible for the phosphorylation of these two 
sugars and that they both compete for a source of high energy phosphate, 
McGarrahan and Maley (30) observed that glucose inhibits the phosphory­
lation of glucosamine. If the glucose-hexokinase system were phlorizi­
din sensitive and the glucosamine-hexokinase system were not, then the 
action of phlorizidin on an organism could favor the phosphorylation 
of glucosamine and possibly account for the observed increase in 
absorption rate and the increased binding of glucosamine in the serum, 
Phlorizidin treatment of the animals fed N-acetyl-D-glueosamine-l-C^* 
significantly increased the total radioactivity in the serum and the 
total radioactivity in the small intestine tissue, and significantly 
decreased the percentage of bound carbon-14 in the small intestine. 
Phlorizidin is known to inhibit the phosphorylation of hexoses.
Since phlorizidin was found to decrease the percentage of bound radio­
activity from absorbed N-acetylglucosamine in the small intestine
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tissue, while causing an increase in the total radioactivity in the 
serum and small intestine tissue, it would appear that phlorizidin 
was inhibiting some process which is essential for the incorporation 
of N-acetylglucosamine into tissue bound hexosamine (possibly the 
phosphorylation of N-acetylglucosamine) and, as a result, the free 
N-acetylglucosamine level increased* The decrease in the absorption 
coefficient for N-acetylglucosamine could possibly also be explained 
on the basis of phlorizidin inhibition of N-acetylglucosamine phos­
phorylation.
In animals treated with phlorizidin and fed either glucosamine 
or N-acetylglucosamine, there was incorporation of the amino sugars 
into tissue bound components (irrespective of degree of incorporation). 
It is significant that, although the urine of the phlorizldin-treated 
animals contained glucosamine, galactose; glucose and mannose, no 
appreciable radioactivity was found associated with these sugars 
except in the animals that had been fed the specific sugar (Tables 
12, 13, and 14), It is known that phlorizidin inhibits the resorption 
of glucose, galactose and mannose in the renal tubles. It follows, 
therefore, that if g l u c o s a m i n e - 1 o r  N-acetylglucosamine were 
converted to any appreciable extent into either glucose, galactose 
or mannose, they would be excreted in the urine.
It may be proposed from the results of the insulin and phlorizidin 
experiments that: (1) permeability of the cell to D-glucosamine
and N-acetyl-D-glucosamine is not a limiting factor in the ^  vivo 
metabolism of D-glucosamine or N-acetylglucosamine, (2) the metabolism
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of intestinally absorbed D-glucosamine and N-acetyl-D-glucosamine is 
by different paths.
CHAPTER V
SUMMÂRV
1, The absorption and metabolism of D-glncosamine and N-acetyl- 
glucosamine In the intact rat has been investigated,
2, Both D-glncosamine and N-acetyl-D-glqcosamine are absorbed from 
the intestine at the same rate; however, the rate is much slower 
than the absorption rate for D-glucose.
3. A portion of the D-glucosamine in the intestinal lumen is apparently 
degraded by the intestinal flora in rats not treated with neomycin.
4. N-acetyl-D-glucosamine is not degraded by the intestinal flora 
in similar animals.
5» Absorbed D—glucosamine and N-acetyl-D-glucosamine are efficiently 
incorporated into hexosamine-containing tissues of the body.
6. A portion of the absorbed N-acetyl-D-glucosamine is deacetylated 
after leaving the lumen of the intestine.
7. A small amount of absorbed N-acetyl-D-glucosamine and D-glucosamine 
is oxidized to carbon dioxide. More N-acetyl—D-glucosamine is 
oxidized to carbon dioxide than is D-glucosamine.
8. In addition to incorporation into tissue hexosamines or oxidation 
to carbon dioxide, absorbed D-glucosamine and N-acetyl-D-glucos­
amine are metabolized to amino acids. There is apparently little
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conversion to hexoses,
9. A portion of absorbed D-glncosamine and N-acetyl-D-glucosamine 
is excreted unchanged in the urine,
10, Insulin apparently facilitates the entry of D-glucosamine and 
N-acetyl-D-glucosamine into the cells; however, it does not 
increase their incorporation into hexosamines of the tissues,
11, Phlorizidin inhibits the absorption of N-acetyl-D-glucosamine 
from the intestine and stimulates the absorption of D-glucosamine,
12, The effects of phlorizidin on the incorporation of D-glucosamine 
and N-acetyl-D-glucosamine into tissues are variable.
list of referekces
1. Cori, C. F,, The Rate of Absorption of Hexoses and Pentoses from
the Intestinal Tract. J. Biol. Chem.. 66. 691 (1925).
2. Kent, P. W., Biochemistry of the Amino Sugars. London;
Buttersworths Scientific Publications, 1955.
5. Dische, Z, and Borenfreund, E., A Spectrophotometric Method 
for the Micro-Determination of Hexosamines, J. Biol. Chem.,
184, 517 (1950).
4. Elson, L. A, and Morgan, W. T. J., A Colormetric Method for
the Determination of Glucosamine and Chondrosamine. Biochem. J.,
27. 1824 (1933).
5. Boyer, R. and Furth, O., Dntersuchungen Zur Charateristik der 
Glucoproteide. Biochem. Z., 282 (1955).
6. Nilsson, I., Zur Bestimmung von Glucosamin in Proteinstoffen. 
Biochem. Z., 2^, 386 (1936).
7. Rimington, C., Seromucoid and the Bound Carbohydrate of the Serum 
Proteins. Biochem. J,, 34, 931 (1940),
8. McLean, J., The Thromboplastin Activity of Cephalin. Amer. J. 
Physiol., 250 (1916).
9. Jorpes, J. E., The Chemistry of Heparin. Hoppe-Seyl. Z., 7,
278 (1943).
10. Wolfrom, M. L., Montgomery, R., Karahime, J. V. and Rathgeb, P., 
Acetylative Desulfation of Carbohydrate Acid Sulfates. J. Amer. 
Chem. Soc., 72, 5796 (1950).
44
45
11. Hoffman, P. and Meyer, K,, Structural Studies of Mucopolysaccharides 
of Connective Tissues. Federation Proc,, 21, 1064 (1962).
12. Purchase, E, R. and Braun, C. E., D-Glucosamlne Hydrochloride,
Org. Synth,, 26, 36 (1946).
13. Meyer, E. and Palmer, J. W., Polysaccharides of Vitreous Humor and 
Umbilical Cord. Am. J, Opthal., 19. 859 (1936).
14. Kaye, M, A* G., Isolation of Sodium Hyaluronate. Nature, Lond.,
166, 478 (1950),
15. Meyer, K. and Chaffee, E., Hyaluronic Acid In the Plural Fluid 
Associated with a Malignant Tumor Involving the Pleura and
Peritoneum. J. Biol. Chem., 133, 83 (1940).
16. Meyer, K. and Damson, M. H., Isolation of Mucopolysaccharide from 
Sjmovlal Fluid. J. Biol. Chem., 128. 319 (1939).
17. Craig, J. M. and Uzman, L, E., A Familial Metabolic Disorder with 
Storage of an Unusual Polysaccharide Complex, Pediatrics, 22,
20 (1958).
18. Spiro, R. G., Glycoproteins: Structure, Metabolism and Biology.
New England J. Med., 269, 566 (1963),
19. Boas, N. F., Bollet, J. A. and Bunlm, J, J., Effect of Acute 
Clinical Stress on the bevels pf Hexosamlne In Serum and Its 
Excretion In the Urine. J. Clin. Investigation. 54, 782 (1955).
20. Quadbeck, G., Hexosamlne Metabolism In Disease of the Central 
Nervous Systen. Inter. Kongr. Neuropathol, Proc., 4, Munich.
212 (1961).
21. Odoardl, G. B., Rambaldl, M. and Verglne, A,, Behavior of Hexoses,
46
Hexosamlne and Glycoproteins in the Serum of Diabetes Mellitus 
Patients. Fisiopatol. Clin. Eicambio., 24, 313 (1960).
22. Glick, D., Methods of Biochemical Analysis, New York; Interscience 
Publishers, Inc., 1955.
23. Shstlar, M, R,, Kelley, K. H., Foster, J. V,, Shetlar, C, L., and
Everett, M, R., Serum Polysaccharide levels in Pregnancy,
Parturition and the Postpartum State. Am. J. Obstetrics and 
Gynecology. 59, 1140 (1950).
24. Ariyama, H. and Takahasi, K., The Relative Nutritive Value of 
Carbohydrates and Related Substances. Biochem. 2.. 216, 269 (1929).
25. Wilson, T, H., and Crane, R. K., The Specificity of Sugar Transport 
by Hamster Intestine. Biochim. Biophys. Acta.. 29, 30 (1958).
26. Ferrando, R. and Henry, N., Biological Effects of Heating Meat in
the Presence of D-Glucosamine. Comp. Rend., 257, 1161 (1963).
27. Becker, C, E. and Day, H. G. Utilization of Glucosamine and 
Synthesis of Glucosamine in the Rat. J. Biol. Chem., 201. 795, 
(1953).
28. Rieder, _S. V. and Buchanan, J, M., Studies on the Biological 
Formation of Glucosamine In Vivo. J .  Biol. Chem., 232, 959 
(195&).
29. Spiro.-R. Gl, Studies on the Biosynthesis of Glucosamine in the 
Intact Rat, J. Biol. Chem.. 234. 742 (1959).
30. McGarrahan, J. F. and Maley, F., The Metabolism In Vivo and
In Vitro of D-Glucosamine-l-C^^ and N-Acetyl-D-Glucosamine-l-C^^ 
in Rat Liver,, Federation Proc., 21, 89 (1962).
67
31. Harpur. R, P. and Quastel. J, H,, Phosphorylation of D-Glucosamine 
by Brain Extracts, Nature, Lond., 164, 693 (1949).
32. Davidson, E, A. Hexokinase from Aspergillus parasiticus. J. Biol. 
Chem., 235, 23 (1960).
32. La zge, C* F, and Kohn, P., Substrate Specificity of Kexokinases,
J. Biol. Chem.. 236, 1 (1961).
34. Ito, T., The Action of Transaminase which Catalyzes the Synthesis 
of Hexosamlne Monophosphate. Seikagaku, 32, 200 (1960).
35. Dorfman. A., Roseman, S., Moses, R. E,, Ludowig, J. and Hayeda, M., 
The Biosynthesis of Hyaluronic Acid by Group A Streptococcus, 
Origin of the N-Acetylglucosamine Moiety. J. Biol. Chem., 212,
583 (1955).
36. Boas, N, F, and Foley, J. B,, Fate of Intravenously Administered 
Glucosamine in the Rat. Proc. Soc* Exp. Biol, and Med., 88, 455 
(1955),
37. Shetlar, M. R., Bradford, R., igern, D,, Endecott, B. and Schilling, 
J. A.,.Fate of Radioactive Glucosamine Administered Parenterally 
to the Rat. Proc. Soc. Exp. Biol, and Med., 109, 335 (1962),
38. Shetlar, .M, R,, Hern, D., Bradford, R. H, and Endecott, B., 
Incorporation of 1-^^C Glucosamine into Serum Proteins, Biochim. 
Biophys, Acta,, 53, 615 (1961),
39. Shetlar, M, R,, Capps, J. C,, and Hern, D. L,, Incorporation of 
Radioactive Glucosamine into the Serum Proteins of Intact Rats 
and Rabbits, Biochim. Biophys. Acta, 83, 93 (1964).
40. Capps, J, C,, ^  Vivo Incorporation of Radioactive Glucosamine 
into Liver Protein of the Rabbit, Thesis. Univ. of Okla., 1961.
48
41, Capps, J» Ç, and Shetlar, M, R,, In Vivo Incorporation of 
D-Glucosamine-l-C^^ into Acid Mucopolysaccharides of Rabbit 
Liver, Proc, Soc, Exp, Biol, and Med,, 114. 118 (1963),
42, Kohn, P,, Winzler, R. J, and Hoffman, R® C,, Metabolism of 
D-Glucosamine and H-Acety1-D-Glucoaamine in the Intact Rat.
J, Biolo Chem.. 237, 304 (1962)®
43, Richmond, J, E,, Studies on the Metabolism of Plasma Glycoproteins, 
Biochemistry. 2, 676 (1963),
44, Brown, D, H,, The Phosphorylation of D-Glucosamine by Crystalline 
Yeast Hexokinase, Biochim, Biophys, .Aeta,, 2» 487 (1951),
45, Brown, D, H,, Action of Phosphoglucomutase on D-Glucosamine-6- 
phosphate, J, Biol, Chem.. 204, 877.(1953),
46, Leloir, L, F, and Cardini, C, E.« The Biosynthesis of Glucosamine, 
Biochim, Biophys, Acta, 12. 15 (1953),
47, Brown, D, H,, The D-Glucosamine-^-Phosphate N-Acetylase of Yeast, 
Biochim, Biophys, Acta,, 16, 429 (1955),
48, Davidson, A,, Blumental, H, J, and. Roseman, S,, Glucosamine 
Metabolism, V. Studies on Glucosamine—6-Phosphate H-Acetylase,
J, Biol. Chem,. 226, 125 (1957),
49, Reissig, J, L,, Phosphoacetylglucosamine Mutase of Heurospora,
J, Biol, Chem,. 219. 753 (1956).
50, Maley, F, and Lardy, H, A,, Formation of DDPGLa and Related Com­
pounds by the Soluble Fraction of Liver, Science. 124. 1207 (1956),
51, Leloir, L, F. and Cardini, C, E,, Ensymes Acting on Glucosamine 
Phosphates, Biochim, Biophys. Acta,, 20, 33 (1956).
49
52, McGarrahan, J, F. and Maley, P., Hexosamine Metabolism. 1. The 
Metabolism In Vivo and In Vitro of D—Glncosamine-l-C^^ and N- 
Acetyl-D-Glucosamine-l-C^"' in Rat Liver. J. Biol. Chem., 257,
2458 (1962).
53, Dorfman, A«, Biosynthesis and Metabolism of Acid Mucopolysaccharides 
of Connective Tissues, Federation Proc», 21, 1070 (1962).
54, Stanely, G. and Strominger, J, L^, Enzymatic Synthesis of N- 
Aeetylglncjaaaminylribitol Linkages in. Teichiolic Acid from 
Staphylococcus aureus, Strain Copenhagen. J, Biol. Chem., 258,
5161 (1965).
55, Roseman, S., Hayes, F. and Ghosh, S., Enzymatic Synthesis of 
N-Acetylmannosamine-6-Phosphate. Federation Proc., 19, 85 (1960).
56, Comb, D. G. and Roseman, S., Enzymatic Synthesis of N-Acetyl-D- 
Mannosamine. Biochim. BiophysActa., 29, 655 (1958).
57, Glaser, L,, On the Mechanism of N-Acetylmannosamine Formation, 
Biochim. Biophys, Acta., 41, 554 (1950),
58, Cardini, C. E,, and Leloir, F., Enzymatic Formation of Acetyl­
galactosamine, J. Biol, Chem,, 225, 517 (1957),
59, Spiro, R. G., The Effect of N-Acetylglucosamine and Glucosamine 
on Carbohydrate Metabolism in Rat Liver Slices, J, Biol, Chem.,
235. 546 (1958),
60, Silverman, J, L., Glucosamine Inhibition of Glucose-1-C^^
Oxidation as Measured by Rat Adipose Tissue In Vitro, Biochim. 
Biophys « Acta, 78, 94 (1965).
61, Voss, H,, Becker, K, and Lindner, J,, Tumor-Inhibiting Action of 
Components of Ground Substances, VI. Comparative Investigations
50
of the Effect of Glucosamine on the Metabolism of Yoshida Rat 
and Ehrlich Mouse Ascites Tumors. Z. Krebsforsch., 65, 228 (1963),
62, Kushida, H,, Biochemical Studies on Hexosamines, X. Effect of 
Hexosamines on the Respiration of Rabbit Liver Tissue, Seikagaku. 
33, 455 (1961).
63. Got, R,, Bourrillon, R. and Michon, J,, Les Constituants 
Glucidiques de la Gonadotropins Choriale Humaine, Bulletin de la 
Societede Chemi Biologique. 62, 41 (1960),
64, Bogdanone, E. M, and Barker, S. B« « Effect of Phlorizin on 
Intestinal Absorption of Glucose, Galactose, Fructose, Mannose and 
Sorbose, Proc. Soc, Exp, Biol. and Med., 75. 77 (1950).
65. Roth, L, J,, Metabolism Cage for Rats. Nucleonics, 14, 104 (1956),
66,_ Jeffay, H. and Alvarey, J,, Liquid Scintillation Counting of 
Carbon-14, Anal. Chem., 33, 612 (1961),
67. Baillie, L, A,, Determination of Liquid Scintillation Counting 
Efficiency by Pulse Height Shift, International Journal of 
Applied Radiation and Isotopes, 8^, 1 (1960),
68, Bruno, G, A. and Christian, J. E., Correction for Quenching 
Associated with Liquid Scintillation Counting. Anal, Chem,, 33,
650 (1961).
69. Rider, P. R., Modern Statistical Methods, New York: John Wiley 
and Sons, 1939,
70. Macleod, J, J. R,, Magee, H. E. and Purves, C. B,, Selective 
Absorption of Carbohydrates. J, Physiol., 70. 404 (1930),
71, MacKay, E, M. and Bergman, H. C., The Rate of Absorption of Glucose 
from the Intestinal Tract. J. Biol. Chem., 101, 453 (1933).
51
72. Pierce, H. B., Osgood, H, S., and Polaqsky, J. B., The Absorption 
of Glucose from the Alimentary Tract of Rats Deprived of the 
Vitamin B Complex, J, Nutrition, 247 (1929).
75, Feyder, S. and Pierce, H. B,, Rates of Absorption and Glyco­
genosis from Various Sugars. J. Nutrition. 9^, 435 (1935).
74. Fenton, P. F., Response of the Gastrointestinal Tract to Ingested 
Glucose Solutions, J. Physiol,, 144. 609 (1945).
75, Clayton, J. D. and Carter, M. K., Renal Clearance of Glucosamine 
in the Rat. Proc. Soc. Exp. Biol, and Med., 114, 788 (1963),
76, Sollmann, T,, A Manual of Pharmacology, Philadelphia: W, B. 
Saunders Co., 1957.
77. Wick, A, N., Drury, D. R., Nakada, H„ I,, Barnet, H. N. and 
Morita, T. N,, Glucosamine and the Action of Insulin. J. Biol, 
Chem., 213, 907 (1955).
APPENDIX
55
TABLE 1
RADIOACTIVITY® ASSOCIATED WITH CHROMATOGRAPHICALLY DETECTED 
SUGARS^ IN INTESTINAL CONTENTS ITIREE HOURS AFTER FEEDING
Sugar Fed Sugar Identity and Radioactivity (c/m)
A. Untreated Animals Glucose Glucosamine N-Acetylelucosamine
D-Glucosamine-1-C^^ (-) 10 (+> 240 (-) 2
N-Ac etyl-D-Glucosamine- 
1-C14 (•*■) 6 (-) 1 (*) 329
B. Neomycin Sulfate 
Treated Animals
D-Glucosamine'-l-C^^ (-) 35 (+) 689 (-) 13
N-Acety1-D-Glucosamine-
1-ci* (+) 10 (-) 5 (+) 235
Radioactivity detected by cutting out aminobiphenyl positive areas 
of the chromatogram and counting the area in the liquid scintillation 
counter,
^A (+) indicates that the sugar was detected with the aminobiphenyl 
reagent.
A (—) indicates that the sugar was not detected with the aminobiphenyl 
reagent; however, the area was counted.
TABLE 2
ABSORPTION OF D-GLUCOSAMINE, N-AGETYL-D-GLUCOSAMINE 
AND D-GLUCOSE DURING A THREE HOUR PERIOD
Sugar Fed 
and Label
No. of 
Animals
Animal -Weights
m i Treatment
Millimoles Sugar 
Absorbed
Absorption
Coefficient
Acetylglucûsamine-1-C^ ^ 9 116 None 0,267 + 0,079 0,077 + 0,023
(110-125) (0,152 - 0,397) (0,043 - 0,120)
Acetylglucosamine-l-C^ ^ 9 137 Neomycin 0,276 + 0,059 0,068 + 0,016
(123-149) (0,204 - 0,365) (0,048 - 0,087)
Acetyl-1-C^ -^Glucosamine 8 121 None 0,256 ± 0,072 0,070 + 0,018
(102-136) (0,183 - 0,305) (0,046 - 0,103)
Glucosamine-1-C ^ ^ 9 111 None 0.307 ♦ 0,062 0,104 ± 0,017
(86-122) (0,227 - 0,388) (0,080 - 0,135)
Glucosamine-l-C^ ^ 9 150 Neomycin 0,276 ± 0,027 0.062 + 0,007
(136-163) (0,210 - 0,298) (0,050 - 0,073)
Glucose-1 9 96 None 0,996 ± 0,009
(91-100) (0,985 - 1.009)
Vjl
•P*
M^illimoles sugar absorbed per 100 gm. body weight per hoiir,.
Values given are the means and their standard deviations. Values in parentheses are the ranges.
TABLE 3
ABSORPTION OF D-GLUCOSE DURING A ONE HOUR PERIOD
V^alues given are means; the range is in parentheses.
Label No. of Animals
Animal Weights 
gms. Treatment
Millimoles Sugar® 
Absorbed
Glucose-1 3 Ill
(100-118)
None 0.919
(0.903-0.935)
Glucose-l-C^ ^ 3 115
(96-126)
Insulin 0.966
(0.952-0,975)
Glucose-l-C^ ^ 3 110
(107-112)
Phlorizidin 0.949
(0.937-0.972) Ul
Ul
table 4
RADIOACTIVITY® IN SERUM FOLLOWING ORAL ADMINISTRATION OF LABELED SUGARS
Sugar Absorbed 
and Label
No, of 
Animafs
Absorption^
Coefficient
Specific Activity 
of Sugw 
(c/m per millimole)
Percentage Absorbed 
Radioactivity 
in Serum
percentage 
Nondialyzable 
Radioactivity 
in Serum
N-Acetyl»D<«Glucosamine~ 
1.C14 b
9 0.068 + 0,016 
(0.048 - 0.087)
4.3 ]: 10® 1.4 1 0.1 
(1.2 - 1.7)
19.7 + 3.5 
(14.8 " 24.9)
N-Acetyl -1 
Glaco'saiaine
8 0.070 + 0.018 
(0.046 - 0.103)
12.1 X 10® 1.2 t 0.2 
(1.0 - 1.4)
26.1 ♦ 7.0 
(19.2 - 41.2)
D-Glucosamine-I-C'^ ^^ 9 0.062 * 0.007 
(0.050 “ 0.073)
17.8 X 10® 2.0 ± 0.2 
(1.7 - 2.2)
35.2 i 8.5 ; 
(22.8 - 50.0)
D-Glucose-lrC'^ 9 0.996 ± 0.009^  
(0.985 - 1.009)
9.5 X 10® 3.0 ± 0.1 
(2.8 - 3.0)
28.8 
(26.9 - 30.1)
Values given are means and their standard deviations. Values in parentheses are the ranges. 
'’Animal8- treated x^ ith neomycin.
M^illimoles sugar absorbed per 100 gm, body weight per hour.
M^illimoles sugar absorbed.
TABLE 5
RADIOACTIVITY® IN LIVER FOLLOWING ORAL ADMINISTRATION OF LABELED SUGARS
Sugar Absorbed 
and Label
No. of 
Animals
Absorption^
Coefficient
Specific Activity 
of Sugar 
(c/m per millimole)
Percentage Absorbed 
Radioactivity 
in Liver
Percentage 
Nondialyzable 
Radioactivity 
ih Liver
N-Acetyl-D-Glucosaraine- 
1-L. ^ ^
9 0,068 4 0.016 
(0.048 - 0.087)
4.3 X 106 2.2 i 0,3 
(1,6 - 2,5)
37.3 + 3.4 
(31.7 - 41,8)
N-Acetyl-l-Cl4_D-
Glucosamine
8 0,070 + 0.018 
(0,046 - 0,103)
12.1 X 106 1,7 1 0,1 
(1,5 - 1,8)
33,8 ± 3.6 
(25,3 - 36,0)
D-Glucoisamine-l-C^ ^^ ' 9 0.062 ± 0.007 
(0.050 - 0,073)
17,8 X 10^ 7,1 ± 0.8 
(6,0 - 8,6)
16,2 t 2.0 
(14.3 - 20.3)
D-Glucose-l-C^ ^ 9 0,996 ± 0,009"^  
(0,985 - 1.009)
9.5 X 10^ 19,7 i 5,3 
(9,4 - 25,8)
45.0 + 7.2 
(32.8 - 58,5)
Vnvj
V^alues given are means and their standard deviations. Values in parentheses are ranges, 
A^nimals treated with neomycin,
M^illimoles sugar absorbed per 100 gm, body weight per hour.
M^illimoles sugar absorbed.
TABLE 6
RADIOACTIVITY^  IN SMALL INTESTINAL TISSUE FOLLOWING ORAL ADMINISTRATION OF LABELED SUGARS
Specific Activity Percentage Absorbed
Percentage
Nondialyzable
Sugar Absorbed 
and Label
No, of 
Animals
Absorption^
Coefficient
of Sugar 
(c/m per millimole)
Radioactivity in 
Small Intestine
Radioactivity in 
Small Intestine
N-Acetyl-D-Glucosamine-
i_ci% b
9 0,068 * 0.016 
(0,048 - 0.087)
4,3 X 10^ 8.7 i 2,6 
(4.3 _ 15,6)
28.6 .1 7,8 
(18.8 - 46,9)
Glucosamine
. 8 0.070 + 0.018 
(0,046 - 0,103)
12.1 X 10^ 9,9 ± 3.8 
(5.8 - 16,4)
45,3 ± 12,3 
(23,4 - 60,7)
D-Glucosamine-l-C^ ^^ 9 0.062 + 0.007 
(0.050 - 0.073)
17,8 X 10^ 12,4 ± 3.0 
(9,3 - 17.7)
23,2 1 5.9 
(12.4 - 30,7)
D-Glucose-l-C^ ^ 9 0,996 ♦ 0.009*^  
(0,985 I 1.009)
9,5 X 10® 6,8 ± 2.7 
(3.3 - 10.4)
99.8 i 14.5 
(77.7 - 119.4)
Vjl
CO
V^alues given are means and their standard deviations. Values in parentheses are the ranges. 
A^nimals treated with neomycin,
CMillimoles sugar absorbed per 100 gm. body weight per hour,
M^illimoles sugar absorbed.
TABLE 7
PERCENTAGE OF RADIOACTIVITY EXPIRED AS CARBON DIOXIDE FROM NEOMYCIN-TREATED 
RATS AND UNTREATED RATS FOLLOWING ORAL ADMINISTRATION OF LABELED SUGARS
Sugar Fed 
and Label
No. of 
Animals
Absorption 
Period(Hours)
Neomycin
Treated
Absorption^
Coefficient
Specific Activity 
of Sugar 
(c/m per millimole)
Percentage 
Absorbed Activity 
Expired as CO^
N“Aeetyl-D"Glueosamine-
l-cl4
9 3 No 0.077^ 0.023 
(0,043-0.120)
4.2 X 10^ 10.1(10.0-10.3)
N-Acetyl-D-Glucosamine-
1_C14
9 3 Yes 0.068*0.016
(0.048^ 0.087)
4.3 X 10® 9.0(6.9-11.2)
N-Acetyl“1 -^D- 
Glucosamine
8 3 No 0.070*0,018
(0.046-0.103)
12.1 X 10® 29.9(28.2-31.6)
D-Glucosaraine-l"C^ ^ 9 3 No 0.104*0,017
(0.080-0.135)
7.8 X 10® 17.9(14.8-19.6)
D-Glucosamine-l-C^ ^ 9 3 Yes 0.062+0.007
(0.050-0,073)
17.8 X 10® 4.5(4.1-5.0)
D-Glucose-l-C^ ^ 9 3 No 0,996+0,009^
(0.985-1.009)
10.9 X 10® 31.4(30.4-32,5)
D-Glucose-l-C^ ^ 3 3 No 20.2 X 108 42.6*’
D-Glucose-l-C^ ^ 3 1 Yes 0.919=
(0.903-0.935)
10,6 X 10® 6.4
Millimoles sugar absorbed per 100 gm„ body weight per hour»
Values given are means and their standard deviations. Values in parentheses arc ranges, 
'^Rats injected intraperitoneally with 2 microcuries D-gïueose-1-C^  ^in saline,
CMillimoles sugar absorbed.
VI
VO
TABLE 8
RADIOACTIVITY^  IN SERUM FOLLOWING ORAL ADMINISTRATION OF LABELED SUGARS 
TO RATS TREATED WITH INSULIN OR PHLORIZIDIN 
(All Animals Treated with Neomycin)
u^gar Absorbed 
and Label
No, of 
Animals
Absorption^
Coefficient
Specific Activity 
of Sugar,
(c/m per millimole)
Percentage Absorbed 
Radioactivity 
in Serum
Percentage 
Nondialyzable 
Radioactivity 
in Serum
A* No Ireatment 
N-Ace^ l^-D-Glucosamine- 9 0.068+0.016
(0.048-0.087)
4.3 X 10® 1.4+0.1 
(1.2-1.7)
19.7+3.5
(14.8-24.9)
D-Glucosamine-l-C^ -^ 9 0.062+0.007
(0.050-0.073)
17.8 X 10® 2.0+0.2 
(1.7-2,2)
33.2+8.5
(22.8-50.0)
B. insulin Treated 
N-Acetyl-D-Glucoaamine- 9 0.062+0.024
(0.030-0,099)
4,3 X 10® 1.4+0.4 
(0.9-2.2)
21.8+5.9
(13.4-30.0)
D-Glucosamine-l-C^ 4 9 0.056+0.011
(0.041-0.070)
13.4 X 10® 2.2+0.4 
(1.7-2.9)
39.4+13,7
(24.3-59.6)
C. Phior iz id in-Treated 
N-Acetyl-D-Glucosamine- 9 0.026+0.015
(0.013-0.053)
4.2 X 10® 1.7+0.5 
(1.1-2.7)
45.9+12.1
(33.3-72.1)
D-Glucosamine-l-G^ *^ 9 0.080+0.016
(0.071-0.105)
14.6 X 10® 1,0+0.2 
(0,8-1.2)
55.1+15.4
(22.9-80.9)
^Values given are means and their standard deviations. Values in parentheses are ranges.
^Millimoles sugar absorbed per 100 gm,. body weight per hour.
TABLE 9
RADIOACTIVITY® IN LIVER FOLLOlflNG ORAL ADMINISTRATION OF LABELED SUGARS 
TO RATS TREATED WITH INSULIN OR PHLORIZIDIN 
(All Animals Treated with Neomycin)
Sugar Absorbed 
and Label
No. of 
Animals
Absorption^
Coefficient
Specific Activity 
of Sugar 
(c/m per millimole)
Percentage Absorbed 
Radioactivity 
in Liver
Percentage 
Nondialyzable 
Radioactivity 
in Liver
A. No Treatment 
H-Acetyl-D-Glucosamine- 
1-C^  ^ .
9 0,068+0.016
(0.048-0.087)
4.3 X 106 2.2+0.3 
(1,6-2.5)
37.3+3.4
(31.7-41.8)
D-Glucosamine-l-c'-^ 9 0,062+0,007
(0.050-0.073)
17.8 X 10^ 7.1+0.8' 
(6.0-8.6)
16.2+2.0
(14.3-20.3)
B. Insulin-Treated 
N-Acetyl-D-Glucosamine- 
1-Cl4
9 0.062+0.024
(0.030-0.099)
4.3 X 106 2.4+0.7 
(1.4-3.5)
40.0+8.8
(24.1-51.4)
D-Glucosamine-l-c'^ ^ 9 0.056+0.011
(0.041-0.070)
13.4 X 10® 6.8+1.5 
(4.5-10.2)
20.5+5.3
(13.9-27.6)
C. Phior iz id in-Tr eated 
N-Acetyl-D-Glucosamine- 
1-0^ 4
9 0.026+0.015
(0.013^ 0.053)
4.2 X 10® 2.1+1,1 
(0.1-5.9)
38.7+11,4
(25.8-57.2)
D-Glucosamine-l-cl^ 9 0.080+0.016
(0.071-0.105)
14.6 X 10® 5.0+0,6 
(4.2-6.3)
15.5+2.6
(11.0-19.1)
^Values given are means and their standard deviations. Values in parentheses
'^Millimoles sugar absorbed per 100 gm, body weight per hour.
are ranges.
a\
TABLE 10
RADIOACTIVITÏ® IN SMALL INTESTINE TISSUE FOLLOWING ORAL ADMINISTRATION OF LABELED SUGARS
TO RATS TREATED WITH INSULIN OR PHLORIZIDIN 
(All Animals Treated with Neomycin)
Sugar Absorbed 
and Label
No, of 
Animals
Absorptionb
Coefficient
Specific Activity 
. of Sugar 
(c/m per millimole)
Percentage Absorbed 
Radioactivity in 
Small Intestine
Percentage 
Nondialyzable 
Radioactivity in 
Small Intestine
A, No Treatment 
N-Ace t^ l-D-Gluc 08 amine- 9 0.068*0.016
(0.048-0.087)
4,3 X 10^ 8.7+2,6 
(4.3-13,6)
28.6+7,8 , 
(18.8-46,9) '
D-01ucosamine-l»C^ .^ 9 0,062*0.007
(0,050-0.073)
17,8 X 10® 12,4+3,0
(9,3-17,7)
23.2+5,9
(12,8-30,7)
B, Insulin-Treated 
N-Acetyl-D-Gluc os amine- 
1-C^ ^
9 0,062+0,024
(0.030”0.099)
4.3 X loG 12,4+4,5
(7,5-18,6)
30.2+9.5
(21,8-46.4)
D-Glucosamine-l-C^ ^ 9 0,056*0.011
(0.041-0.070)
13,4 X 10^ 8.7*2,5 
(5,5-13,2)
26.0*8.5
(20,4-42.3)
C, Phior i z id in-Tr eated 
N-Acetyl-D-Glucosamine- 
1-C^ 4
9 0.026*0.015
(0.013-0.053)
4,2 X 106 25,9*10,1
(9.6-32,4)
19,1+5,3
(12.7-29,5)
D-Glucosamine-I-Cl^ 9 0.080*0.016
(0.071-0,105)
14,6 X 10® 10,2+3,2
(6,4-15,2)
24.4*9.9
(12.7-46,4)
Values given are means and theif standard deviations. Values in parentheses are ranges,
^Millimoles suf;ar absorbed pet 100 gm,. body weight per hour.
TABLE 11
EFFECT OF INSULIN AND PHLORIZIDIN ON THE ABSORPTION OF D-GLUCOSE, D-GLUCOSAMINE 
AND N-ACETYL-D-GLUCOSAMINE AND THEIR CONVERSION TO CARBON DIOXIDE 
IN NEOMYCIN-TREATED RATS
Sugar Fed 
and Label
No. of 
Animals
Period of 
Absorption 
(Hours)
Absorption^
Coefficient
Specific Activity 
ot Sugar 
(c/m per millimole)
Percentage 
Absorbed Activity 
Expired as CO2
A. No Treatment 
N-Acetyl-D-Glucosamin' » 
l-C^ ^
9 3 0.068+0,016
(0.048-0.087)
4,3 X 10® 9.0
(6.9-11.2)
D-Glucosamlne-l-C^ ^ 9 3 0.062+0.007
(0.050Z0.073)
17.8 X 10® 4.5 
(4.1-5.0)
D-Glucose-l-C^ ^
B. Insulin-Treated 
N-Acetyl-D-Glucosamine- 
l-C^ ^
3
9
1
3
0.831
(0.778-0,955)
0.062+0.024
(0.030-0.099)
10.6 X 
4,3 X
10®
10®
6.4
11.8
(9.3-14.9)
D-Glucosamine-l-C^ ^ 9 3 0.056+0,011
(0.041-0.070)
13,4 X 10® 8.2 
(7.2-9.3)
D-Glucose-l-C^ ^ 9 1 .0.868 10,6 X 10® 9.9
C. Phlorizidin-Treated 
N-Acetyl-D-Glucosamine~
1-0^4
9 3 0.026+0.015
(0.013-0.053)
4.2 X 10® 11.5
(9.1-14,6)
D-Glucosamine-l-C^ ^ 9 3 0.080+0.016'
(0.071-0.105)
14.6 X 10® 3.1 
(3.0-3.1)
D—Glucose—1—C^ ^ 3 1 0.863
(0.847-0.876)
11,6 X 10® 5.0
^Values given are means and their standard deviations.
Millimoles sugar absorbed per 100 gm, body weight per
-Values in parentheses are ranges, 
hour.
TABLE 12
RADIOACTIVITY® ASSOCIATED WITH CHROMATOGRAPHICALLY DETECTED SUGARS*^  IN URINE FROM RATS 
FED D-GLUCOSE-l-C^  ^^ ND TREATED WITH NEOMYCIN, INSULIN OR PHLORIZIDIN
Sugar Identity and Radioactivity (c/m)
Period
(Hours) Treatment
Uronic
Acid Glucosamine Galactose Glucose
Acetyl- 
Mannose glucosamine
1 Neomycin (-)4 (-)O (-)O (-)4 (-)l (-)O
1 Neomycin Insulin (-)l (-)O (-)3 (-)6 (-)3 (-)6
1 Neomycin —  Phlorizidin (-)l (-)2 (+)13 (+)395 (+)65 (-)4
3 “““ (-)O (-)O (-)O (-)O (-)O (-)O
R^adioactivity detected by cutting out aminobiphenyl positive areas of the chromatograms and counting the 
area in the liquid scintillation counter.
*^A (+) indicates that the sugar was detected with the aminobiphenyl reagent,
A (r) indicates that the sugar was not detected with the aminobiphenyl reagent; however, the area was counted.
TABLE 13
RADIOACTIVITY^  ASSOCIATED WITH CHROMATOGRAPHICALLY DETECTED SUGARS*’ IN URINE FROM RATS 
FED N-ACETYL-D-GLUCOSAMINE-1-C^  ^and N-ACETYL-1-C^ -^D-GLUCOSAMINE 
AND TREATED WITH NEOMYCIN, INSULIN OR PHLORIZIDIN
Sugar and Sugar Identity and Radioactivity (c/m)
Label
Fed Treatment
Uronic
Acid Glucosamine Galactose Glucose Mannose
Acetyl-
glucosamine
A, N-Acetyl-D- 
glucosamine-l?C*-^ — —  (+)11 (-)O (-)3 (+)0 (-)2 (+)60
Neomycin —  (+)4 (-)O (-)4 (+)3 (-)l (+)86
Neomycin Insulin -- (+)7 (-)7 (-)7 (+)5 (-)4 (+)135
Neomycin Phlorizidin(+)0 (+)9 (+)1 (+)7 (+)2 (+)35
B, N-Acetyl-1- 
C^ -^D-Glucosamine ——— (+)1 (-)O (-)3 (+)2 (-)4 (+194)
Radioactivity detected by cutting out aminobiphenyl positive areas of the chromatogram and counting the 
areas in the liquid scintillation counter,
*^A (+) indicates that the sugar was detected with the aminobiphenyl reagent.
A (-) indicates that the sugar was not detected with the aminobiphenyl reagent; however, the area was counted.
TABLE 1.4
RADIOACTIVITY® ASSOCIATED WITH CHROMATOGRAPHICALLY DETECTED SUGARS^  IN URINE FROM RATS 
FED D-GLUCOSmiNE-l-C^  ^AND TREATED WITH NEOMYCIN, INSULIN OR PHLORIZIDIN
Treatment
Uronic
Acid Glucosamine Galactose Glucose Mannose
Acqtyl-
glucosamine
— - —— (-)O (+)50 (-)l (-)O (-)O (-)O
Neomycin —— (+)34 (+)591 (-)16 (4)6 (-)4 (-)8
Neomycin Insulin (-)2 (+)227 C-)5 (-)2 (-)2 (-)6
Neomycin Insulin Phlorizidin (+)7 (4)259 (4)5 (4)2 (4)1 (-)3
R^adioactivity detected by cutting out aminobiphenyl positive areas of the chromatogram and counting the areas 
in the liquid scintillation counter.
A^ (+) indicates that the sugar was detected with the aminobiphenyl reagent.
A (-) indicates that the sugar was not detected with the aminobiphenyl reagent; however, the area was counted.
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TABLE 15
RADIOACTIVITY OF TISSUE HYDROLYSATE FRACTIONS
Tissue Hydrolyzed
Total
Radioactivity
Percentage Total 
Radioactivity in 
Column Fractions
and Source of Animal Treated of Column Amino
Label with Neomycin Eluate Water Wash Hexosamines Ac ids
A, B-Glucosamine- 
1-C14
Serum No 479 2.5 58.5 38.6
Serum Yes 222 1,4 78,8 19.8
Liver No 1042 14.5 24.4 61.1
Liver Yes 194 7.7 68.0 24.2
Smal1 Intestine No 1057 2.8 65.7 31,4
Small Intestine Yes 513 2.0 86.0 12.1
B. N-Acetyl-D- 
Glucosamine-L-C^^
Serum No 51 7.8 45.1 47.1
Serum Yes 47 2.1 36.2 61.7
Liver No 234 15.0 30.3 54.7
Liver Yes 163 7,4 35.0 57.7
Small Intestine No 218 1.8 65.1 33.0
Small Intestine Yes 175 3.4 68,6 28.0
y*
' / J
T ; ' j  ^
- i
J. 1
 P, / .
.0 - - 4-^ â__JW a
■fes3 - I
u
;^ ,S2ag«r»¥5i&j5hSÆ-'..î&-- H g M
J
